Fenofibrate-induced liver injury

被引：24

作者：

Dohmen, Kazufumi ^{[1
]}

Wen, Chun Yang ^{[2
]}

Nagaoka, Shinya ^{[2
]}

Yano, Koji ^{[2
]}

Abiru, Seigo ^{[2
]}

Ueki, Toshihito ^{[2
]}

Komori, Atsumasa ^{[2
]}

Daikoku, Manabu ^{[2
]}

Yatsuhashi, Hiroshi ^{[2
]}

Ishibashi, Hiromi ^{[2
]}

机构：

[1] Okabe Hosp, Umi, Fukuoka 8112122, Japan

[2] Natl Nagasaki Med Ctr, Clin Res Ctr, Omura 8568562, Japan

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2005年 / 11卷 / 48期

关键词：

D O I：

10.3748/wjg.v11.i48.7702

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：7702 / 7703

页数：2

相关论文

共 9 条

[1]

Dohmen K, 2004, WORLD J GASTROENTERO, V10, P894

[2]

Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway [J].

Edgar, AD ;

Tomkiewicz, C ;

Costet, P ;

Legendre, C ;

Aggerbeck, M ;

Bouguet, J ;

Staels, B ;

Guyomard, C ;

Pineau, T ;

Barouki, R .

TOXICOLOGY LETTERS, 1998, 98 (1-2) :13-23

[3]

Bezafibrate in the treatment of primary biliary cirrhosis: Comparison with ursodeoxycholic acid [J].

Kurihara, T ;

Niimi, A ;

Maeda, A ;

Shigemoto, M ;

Yamashita, K .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10) :2990-2992

[4]

Miyaguchi S, 2000, HEPATO-GASTROENTEROL, V47, P1518

[5]

Nakai S, 2000, AM J GASTROENTEROL, V95, P326

[6]

Ohira H, 2002, AM J GASTROENTEROL, V97, P2147

[7]

Simvastatin in primary biliary cirrhosis:: effects on serum lipids and distinct disease markers [J].

Ritzel, U ;

Leonhardt, U ;

Näther, M ;

Schäfer, G ;

Armstrong, VW ;

Ramadori, G .

JOURNAL OF HEPATOLOGY, 2002, 36 (04) :454-458

[8]

Steiner G, 2001, LANCET, V357, P905

[9]

Yano K, 2002, AM J GASTROENTEROL, V97, P1075